PhorMed Inc

08/05/2022

Phormed published a Press Release on the 3rd of August 2022, announcing that the company has discovered its study drug works on ARDS, a lung disorder caused by COVID-19 amongst other causes. The company is now in the process of filing a Phase 2 human clinical trial to treat ARDS. Click https://www.startengine.com/phormed/updates to go to the company’s Equity Crowd Funding Update section on the StartEngine platform and see why PhorMed can bypass Phase 1 (see the ‘Q&A’ post) and the Press Release.

You can invest today and be part of bringing better medical treatment to those in need.
Best regards, From The PhorMed Team. https://www.startengine.com/phormed.

06/13/2022

PhorMed is paving the way in the field of genomic medicine.

Learn more at www.startengine.com/phormed and look for time-based information today!

05/31/2022

Please take a moment to visit our webpage at https://www.startengine.com/phormed to find out more about our technology and take advantage of time-based rewards

05/23/2022

PhorMed is excited to announce the launch of our second StartEngine campaign! Our last campaign close was very successful thanks to all our Investors. We have set hefty goals, but all can be accomplished with the proper funding and support. We would like your help expanding the PhorMed Family by introducing new investors and bring us closer to our final goals. We are looking forward to an exciting year ahead. Best regards, From The PhorMed Team. https://www.startengine.com/phormed

03/25/2022

Campaign Closing Tomorrow
Visit https://www.startengine.com/phormed and click Invest to become part of the PhorMed family

02/05/2022

02/01/2022

Exciting news: PhorMed reaches $2million raised milestone

We are excited to announce that with your investments PhorMed has raised $2 Million so thank you investors!
With your continued support we can bring our exciting GENOMIC REPAIR TECHNOLOGY to those who need it.
Invest at https://www.startengine.com/phormed to become a new member of the PhorMed family and help modernize medicine.
Please pass on the word to assist us in reaching our next milestones.
Thank you from The PhorMed family

01/13/2022

Best Wishes for 2022

12/28/2021

Happy Holidays and sincere thanks to all our Investors and Followers from the PhorMed team.